Sign in
Explore the registryTrack Fluorouracil's trials

DG-03

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

Fluorouracil (5-FU)OngoingActive not recruitingPhase 2Open NCT04379596 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

DG-03 · Trial Tracker · ComplyRx